Effect of Systemic Cooling in Vasospasms

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2004-09-30

Study Completion Date

2006-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study tests whether women with Vasospastic Syndrome (VS) react more intensive than controls with distal vasomotions and choroidal blood flow changes to internal cooling/warming and external cooling/warming.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Distal vasomotions and choroidal blood flow changes to internal cooling/warming and external cooling/warming was studied in VS and controls.Core cooling was induced by drinking of 250g ice/water mixture (4°C). Core warming was induced by drinking of 250g warm water (55°C). The study was controlled with respect to posture and room temperature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Vasospastic Syndrome

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

vasospastic women controls core cooling core warming external cooling external warming LDF choroidal blood flow temperature vasospastic subjects normal subjects

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women
* luteal phase or contraceptives
* 19-35 years

Exclusion Criteria

* somatic diseases
* psychiatric diseases
* BMI \> 25
* BMI \< 18

Minimum Eligible Age

19 Years

Maximum Eligible Age

35 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

University Hospital, Basel, Switzerland

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Selim Orguel, MD

Role: STUDY_DIRECTOR

Unversity Eye Clinic Basel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Eye Clinic

Basel, Basel, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

007-KRK-2004-001

Identifier Type: -

Identifier Source: org_study_id